April 5, 2010 Issue | Chemical & Engineering News
 
 

C&EN congratulates Dan Fagin on winning the 2014 Pulitzer Prize in General Nonfiction for “Toms River: A Story of Science and Salvation” (Bantam Books). C&EN’s Rudy Baum reviewed “Toms River” last May.

 
Copyright © 2010 American Chemical Society
 

April 5, 2010 Issue

Volume 88, Issue 14
8814cover_patentBig
April 5, 2010 Issue, Vol. 88 | Iss. 14
Alzheimer's researchers will soon know whether blocking amyloid-β can slow down the debilitating disease
By Lisa M. Jarvis
(pp. 12-17)
Features
Business
Sangamo Biosciences wants genome editing technology to touch on multiple application areas (pp. 20-23)
Government & Policy
Measurement agency gets facelift with new director, more focused mission (pp. 30-32)
Back Issues
 

Cover Story: The Amyloid Question

'Beta Testing'
ACS Meeting News: Using chemistry tools to refine an Alzheimer's drug candidate
(p.14)
The Dimebon Debacle
Medivation and Pfizer salvage what they can from the failure of a large Phase III trial for a promising Alzheimer's drug
Web Exclusive
 

News of the Week

Survival Of The Weakest

Catalyst Discovery: Least stable intermediates can lead to the best catalysts
(p.7)

EPA Targets Bisphenol A

Regulation: Agency will examine levels of plastics chemical in water supply and effects on wildlife
(p.8)

Thorium Complex Almost Maxes Out

Inorganic Chemistry: 15-Coordinate thorium aminodiboranate sets a record, just one bond short of a perfect 16
(p.8)

Climate Change

EPA Lays Out Plans To Cut Co2, Other Greenhouse Gas Emissions
(p.9)

Gene Patents Ruled Invalid

Biotechnology: Industry says setback will not undermine multi-billion-dollar business
(p.9)

Countering Sleeping Sickness

Drug Development: New compounds cure mice of early-stage infections
(p.10)

Earth-Friendly Chlorine

Technology: Bayer’s new cathode saves energy, reduces greenhouse gas emissions
(p.10)

BP Shuts Its Last U.S. Solar Plant

Manufacturing: Price drop spurs shift to China and India
(p.11)

Talking About Geoengineering

Climate Intervention: California conference calls for research that is responsible and open
(p.11)
 

Departments

8814bus1_BreakPoint

Business

Sangamo Biosciences wants genome editing technology to touch on multiple application areas
(pp. 20-23)
After two big departures, business is good for remaining players
(pp. 24-26)
Under new leadership, SOCMA broadens its trawl for batch manufacturers
(pp. 27-28)
ACS Meeting News: Using chemistry tools to refine an Alzheimer's drug candidate
(p.14)
Eastward Expansion: Plans call for doubling cellulosic capacity in China
(p.18)
8813overview1a

Government & Policy

Measurement agency gets facelift with new director, more focused mission
(pp. 30-32)
Renowned scientist recognized for his public service in science and technology
(p.29)
8814cov1_dimebon

Science & Technology

Medivation and Pfizer salvage what they can from the failure of a large Phase III trial for a promising Alzheimer's drug
Web Exclusive
Alzheimer's researchers will soon know whether blocking amyloid-β can slow down the debilitating disease
(pp. 12-17)
ACS Meeting News: Analytical chemists devise methods to confirm foods are what they claim to be
(pp. 36-37)
ACS Meeting News: Increasing computational power makes possible simulations of geology's nitty-gritty chemistry
(pp. 39-40)

Editor's Page

This guest editorial is by Ted Kaufman, Democratic senator from Delaware.
(p.3)